483 AstraZeneca Pharmaceuticals LP Aug 2018

483 AstraZeneca Pharmaceuticals LP Aug 2018

Jonathan Chapman FDA, Qin Xu FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Frederick, MD, United States facility and issued inspectional observations (via FDA 483) on 17 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Aug 2018
  • Location: Frederick, United States
  • FEI: 3002617771
Add To Cart